Cytoagents, Inc.

Innovative Treatments for CRS and ICANS | CytoAgents

PITTSBURGH, United States · Founded 2020 · $14.6M raised

Employees
1–10
Founded
2020
Total Funding
$14.6M
Last Round
$7.0M Venture RoundMay 2023
Rounds
3

About

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Summary

Cytoagents, Inc. is a company based in PITTSBURGH, United States, founded in 2020. It has raised $14.6M in total across 3 rounds, most recently a $7.0M Venture Round round in May 2023. Investors include Pittsburgh Life Sciences Greenhouse, Penn Cove Group and National Institutes of Health.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Venture RoundVenture RoundMay 2023
$7.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors